BioWorld Asia

April 9, 2003

View Archived Issues

Serono Signs On Graffinity As Partner For Drug Development

Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld International) Read More

Epigenomics Raises EUR21M To Fund Work In DNA Methylation

Read More

Angiogenesis Study Encourages Prospects In Ischemia Treatment

Read More

GeneProt Slashes Staff, Cites Current Economic Environment

Read More

Ester Neuroscience Gets Good Results In Early Antisense Trial

Read More

Chiasma Gets First Biotech Investment From InnoMed

Read More

Galapagos Enters Collaboration In Nutraceuticals With Degussa

Read More

European Officials Craft Report On Embryonic Stem Cell Research

Read More

SR Pharma Taking Stock After Acquiring Rodaris, Joint Venture

Read More

EBML Targets Young Companies In Europe With New EUR25M Fund

Read More

Bioline Therapeutics Formed By Israeli Groups With $11M Funding

Read More

Other News To Note

Read More